Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2
Conditions
Brief summary
This study is conducted in Japan. The aim of this study is to evaluate the incidence of severe hypoglycaemia under normal clinical practice.
Interventions
DRUGinsulin aspart
Prescribed by the physicians as a result of normal clinical practice
Sponsors
Novo Nordisk A/S
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
* Patients with no treatment history of insulin aspart (NovoRapid®)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Occurrence of severe hypoglycaemic symptoms | Year 1 |
| Antibody titre findings | Year 1 |
| Adverse events | Year 1 |
Secondary
| Measure | Time frame |
|---|---|
| Response rate assessed by the investigator: Ability or failure to achieve expected glycaemic control | Year 1 |
| HbA1c (glycosylated haemoglobin) | Year 1 |
| Total dose of insulin infused subcutaneously | Year 1 |
Countries
Japan
Outcome results
None listed